Semaglutide

FDA Approved

Semaglutide

Aliases
Ozempic, Wegovy, Rybelsus
Administration
Subcutaneous injection (weekly), Oral tablet (daily)

Documented side effects

Tier 1 · Peer-reviewed / regulatory

GI symptoms (most common)

Nausea, vomiting, or diarrhea are the most frequently reported effects, especially when starting or increasing the dose.

Rare pancreatitis

An uncommon but serious inflammation of the pancreas has been reported in rare cases.